Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteins
- 31 July 1993
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 17 (1) , 35-39
- https://doi.org/10.1016/0732-8893(93)90067-h
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/IIBlood, 1992
- Segregation of Human T Cell Lymphotropic Virus Type I and II Infections by Antibody Reactivity to Unique Viral EpitopesThe Journal of Infectious Diseases, 1992
- Identification of immunodominant epitopes in envelope glycoprotein of human T Lymphotropic virus type IIVirology, 1992
- A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type IJournal of General Virology, 1991
- Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithmsJournal of Clinical Microbiology, 1991
- Serologic Discrimination of Human T Cell Lymphotropic Virus Infection by Using a Synthetic Peptide-Based Enzyme ImmunoassayThe Journal of Infectious Diseases, 1991
- Expression of HTLV-I Envelope Protein Fused to Hydrophobic Amino-Terminal Peptide of Baculovirus Polyhedrin in Insect Cells and Its Application for Serological AssaysAIDS Research and Human Retroviruses, 1990
- Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donorsBlood, 1989
- Seroprevalence and Epidemiological Correlates of HTLV-I Infection in U.S. Blood DonorsScience, 1988
- Diagnostic Potential for Human Malignancies of Bacterially Produced HTLV-I Envelope ProteinScience, 1984